| Exocrine Pancreas Carcinoma studied in …STUDIED_INderived200 of 919show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Exocrine Pancreas Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04548752Phase 2 · active not recruiting Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04605913Phase 1/Phase 2 · active not recruiting Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06608927Phase 3 · active not recruiting Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845617recruiting Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482893Phase 1/Phase 2 · recruiting Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06388967recruiting Pancreatic Cancer Detection Consortium · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621718Phase 3 · recruiting Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005493Phase 1/Phase 2 · recruiting Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06428409Phase 1/Phase 2 · recruiting A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989437Phase 2/Phase 3 · recruiting A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562152Phase 3 · recruiting Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670312Phase 1/Phase 2 · recruiting Evaluation of XYA02 in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882746Phase 1 · terminated A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07252232Phase 3 · recruiting Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07344220Phase 2 · enrolling by invitation Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291651recruiting UCSF PANC Cyst Registry · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06128551Phase 1/Phase 2 · recruiting Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445062Phase 1/Phase 2 · recruiting Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409272Phase 3 · recruiting A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488676Phase 1/Phase 2 · recruiting A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619521Phase 1/Phase 2 · recruiting Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769502Phase 2 · recruiting A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543071Phase 2 · active not recruiting Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07629960Phase 1/Phase 2 · recruiting A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07645651Phase 1 · recruiting Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831330Phase 2 · not yet recruiting Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435038Phase 1/Phase 2 · recruiting Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07450859Phase 2 · recruiting A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827053Phase 2 · not yet recruiting Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828236Phase 1 · not yet recruiting PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829185Phase 1 · not yet recruiting Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06275737NA · recruiting POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349537Phase 1 · recruiting Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06574620NA · recruiting Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05692596active not recruiting The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412510Phase 1/Phase 2 · active not recruiting Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255001NA · recruiting Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702292Phase 2 · recruiting [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111172Phase 2 · suspended A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799274Phase 1 · active not recruiting Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07491445Phase 3 · recruiting Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01585805Phase 2 · active not recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665947early Phase 1 · active not recruiting First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077800Phase 2 · active not recruiting FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365581Phase 1 · recruiting A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651580recruiting Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Exocrine Pancreas Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07081360Phase 3 · recruiting Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148830NA · recruiting Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma. · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514497Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524973NA · recruiting Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812805Phase 1 · recruiting SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660971Phase 1 · active not recruiting Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05685602Phase 1 · suspended CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05968326Phase 2 · active not recruiting A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06597721Phase 1 · recruiting ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878163Phase 1 · active not recruiting GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662879NA · active not recruiting Early Detection Initiative for Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861452Phase 1/Phase 2 · recruiting Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805954Phase 3 · recruiting Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07806110Phase 2 · active not recruiting Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or Without SHR-1701 as Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807956Phase 1 · not yet recruiting A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03608631Phase 1/Phase 2 · recruiting iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04005690early Phase 1 · recruiting Targeted Pathway Inhibition in Patients With Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04340141Phase 3 · active not recruiting Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05372614Phase 1 · recruiting Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06390059Phase 2 · completed EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090499Phase 1 · recruiting A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803770not yet recruiting EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803783Phase 3 · not yet recruiting A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04493060Phase 2 · completed Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05141643early Phase 1 · active not recruiting Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07644559Phase 2 · recruiting A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245500Phase 1 · recruiting Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06673017Phase 1 · recruiting PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024615Phase 1 · recruiting A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07799298NA · not yet recruiting Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID) · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04172532Phase 1/Phase 2 · recruiting Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305247Phase 1/Phase 2 · active not recruiting A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07573215approved for marketing Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796997Phase 1 · not yet recruiting GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06698458NA · recruiting Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227168Phase 1 · recruiting A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630961Phase 1 · recruiting Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07640295Phase 1/Phase 2 · recruiting Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04157127Phase 1 · recruiting Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07787156NA · not yet recruiting Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02206360completed Pancreatic Cancer Early Detection Program · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958328Phase 3 · recruiting Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084481Phase 1 · recruiting Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586515Phase 1 · recruiting MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554367Phase 2 · active not recruiting Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Exocrine Pancreas Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843551Phase 2 · recruiting The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07274657NA · recruiting Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619313Phase 1 · recruiting AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776353recruiting Understanding New Cachexia Subtypes Through Observational Epidemiological Research · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777211Phase 1/Phase 2 · active not recruiting A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07175389Phase 1/Phase 2 · not yet recruiting JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214298Phase 1/Phase 2 · recruiting Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226154recruiting Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07542041NA · recruiting Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895709Phase 1/Phase 2 · recruiting A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07157033Phase 1/Phase 2 · recruiting A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04896073Phase 2 · completed Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP) · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286827Phase 2 · terminated Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07700212Phase 1 · not yet recruiting A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05985655Phase 1/Phase 2 · recruiting Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115163Phase 2 · active not recruiting Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05737615Phase 1 · withdrawn PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04887805Phase 2 · active not recruiting Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05706129Phase 1/Phase 2 · recruiting A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03851614Phase 2 · active not recruiting Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05518903Phase 2 · recruiting Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06576115Phase 2 · recruiting Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733674Phase 1 · recruiting Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06157671enrolling by invitation The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06168812Phase 2 · active not recruiting A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07043270Phase 2 · recruiting 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594067Phase 1 · recruiting TCR1188-ABC Cells in KRAS-mutated Cancers · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07748611Phase 2 · not yet recruiting SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04999761Phase 1 · recruiting AB122 Platform Study · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021066Phase 1 · active not recruiting Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083599Phase 1/Phase 2 · active not recruiting GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05132504Phase 2 · recruiting Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745790Phase 2 · not yet recruiting Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07597252not yet recruiting ctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616534Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06921928Phase 1/Phase 2 · active not recruiting Study for AZD4360 in Participants With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657068Phase 1/Phase 2 · recruiting A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06710132Phase 1/Phase 2 · active not recruiting Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04990609Phase 2 · recruiting EUS-RFA PANCARDINAL-1 Trial · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06219941Phase 2 · recruiting AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06562192Phase 1 · recruiting Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255404Phase 2 · recruiting A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07701486Phase 1/Phase 2 · recruiting A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03410030Phase 1/Phase 2 · completed Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05034627Phase 1 · completed Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05376592recruiting Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07589205Phase 1 · recruiting Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723781not yet recruiting Structured Case-Finding for Pancreatic Ductal Adenocarcinoma in Swiss Primary Care: A Feasibility Study · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04970056recruiting Pancreatic Cancer Early Detection Consortium · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05208762Phase 1 · recruiting A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06131840Phase 1 · recruiting A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816358Phase 1 · active not recruiting Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04669197Phase 2 · completed Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05055323Phase 1 · active not recruiting A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607185Phase 1 · active not recruiting A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710495NA · recruiting Exercise to Improve Outcomes in Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711067Phase 2/Phase 3 · not yet recruiting A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03856658Phase 2 · active not recruiting Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189195Phase 1 · recruiting TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07709052not yet recruiting Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365169NA · recruiting Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528093Phase 1 · terminated A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705919Phase 1/Phase 2 · not yet recruiting DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816163Phase 2 · active not recruiting A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07699757Phase 1 · not yet recruiting HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07700992recruiting A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05000294Phase 1/Phase 2 · recruiting Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451849Phase 1/Phase 2 · terminated A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04233866Phase 2 · active not recruiting Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05355298Phase 1/Phase 2 · active not recruiting ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05726864Phase 1/Phase 2 · active not recruiting A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07083479no longer available Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07678593Phase 1/Phase 2 · not yet recruiting A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05632328Phase 2 · active not recruiting AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06282809NA · recruiting The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06464965Phase 1 · completed Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06585488Phase 1 · terminated A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06147037Phase 1 · active not recruiting A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466187Phase 1 · terminated A Study of SGN-MesoC2 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224750recruiting A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106856Phase 1 · completed Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04477343Phase 1 · active not recruiting A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06710756Phase 1/Phase 2 · recruiting Lead-212 PSV359 Therapy for Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07683845recruiting Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04809766Phase 1 · terminated Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07022015NA · recruiting Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06015724Phase 2 · active not recruiting Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07458347Phase 1 · recruiting A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07665684Phase 1/Phase 2 · not yet recruiting Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer · condition mapped ALIAS · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432633Phase 1/Phase 2 · recruiting [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483726NA · completed Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05346536NA · recruiting Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975516Phase 2 · terminated Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05867121Phase 1 · completed A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381154Phase 2 · active not recruiting Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02600949Phase 1 · enrolling by invitation Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer · condition mapped CURATED_BROADER · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07219238Phase 2/Phase 3 · recruiting Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) · condition mapped ONTOLOGY_EXACT · 919 trials mapped (414 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |